In the United States, hepatitis C virus (HCV) is the major etiologic agent of chronic viral hepatitis. The majority of infected individuals will develop progressive liver disease, which may include cirrhosis and hepatocellular carcinoma. Research on HCV has been severely hampered by the lack of an in vitro cell culture system and an adequate animal model. As a result, effective therapies against HCV have yet to be developed. Treatment with interferon is currently the only available therapy for HCV infection. Unfortunately, less than 50 percent of patients treated with high doses of interferon show a sustained response with eradication of HCV. A possible genetic basis for interferon resistance has been identified in a small, highly conserved domain of the NS5A gene product of HCV-1b, termed the interferon sensitivity determining region (ISDR). It is thought that NS5A may mediate HCV resistance to interferon by interacting with one or more interferon-induced cellular proteins associated with the interferon antiviral response. The P.I. laboratory has demonstrated that NS5A directly interacts with the interferon-induced proteins kinase, PKR, a primary mediator of the antiviral effects of interferon. Significantly, the ISDR appears to be required for this interaction. It is their hypothesis that NS5A is responsible for mediating HCV resistance to interferon therapy, at least in part, through a direct interaction with PKR. To test this hypothesis, they will use a multifaceted approach to characterize and define the interaction of NS5A with PKR. Specific goals of this proposal include: (1) an in- depth structure-function analysis of the NS5A-PKR interaction. NS5A deletion mutants will be constructed and site-specific mutations introduced into NS5A using mutD5 mutagenesis. Mutant NS5A constructs will be examined using in vitro and in vivo assays for PKR activity as well as for ability to reverse the PKR-induced slow-growth phenotype in yeast. (2) Establishment of stable NS5A-expressing Huh- 7 cell lines to examine the effects of NS5A on PKR function and activity and to obtain information regarding, the biological role of NS5A in HCV-infected cells. Stable NS5A-expressing NIH 3T3 cell lines will also be constructed to examine the potential role of NS5A in transformation and tumorigenesis. (3) Identification of NS5A phosphorylation sites in vivo. The importance of such sites for NS5A function will be examined by site-directed mutagenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041629-05
Application #
6373671
Study Section
Virology Study Section (VR)
Program Officer
Johnson, Leslye D
Project Start
1997-07-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2003-06-30
Support Year
5
Fiscal Year
2001
Total Cost
$235,726
Indirect Cost
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Walters, Kathie-Anne; Katze, Michael G (2009) Using high-throughput genomics to study hepatitis C: what determines the outcome of infection? Antiviral Res 81:198-208
He, Yupeng; Yan, Wei; Coito, Carlos et al. (2003) The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins. J Gen Virol 84:535-43
He, Yupeng; Katze, Michael G (2002) To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunol 15:95-119
He, Yupeng; Nakao, Haruhisa; Tan, Seng-Lai et al. (2002) Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 76:9207-17
Kash, John C; Cunningham, Dawn M; Smit, Maria W et al. (2002) Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis. J Virol 76:10417-26
Tan, S L; Katze, M G (2001) How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 284:1-12
He, Y; Tan, S L; Tareen, S U et al. (2001) Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J Virol 75:5090-8
Geiss, G K; An, M C; Bumgarner, R E et al. (2001) Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 75:4321-31
Gale Jr, M; Tan, S L; Katze, M G (2000) Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev 64:239-80
Melville, M W; Katze, M G; Tan, S L (2000) P58IPK, a novel cochaperone containing tetratricopeptide repeats and a J-domain with oncogenic potential. Cell Mol Life Sci 57:311-22

Showing the most recent 10 out of 25 publications